Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Sun Pharmaceutical Industries Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

23 Jul 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Sun Pharmaceutical Industries Ltd (SUNPHARMA-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

24 Jul 2016 Thomson Reuters Stock Report 11 $25.00

Sun Pharmaceutical Industries Limited (SUNPHARMA) - Financial and Strategic SWOT Analysis Review

Sun Pharmaceutical Industries Limited (SUNPHARMA) - Financial and Strategic SWOT Analysis Review Summary Sun Pharmaceutical I...

07 Jul 2016 GlobalData 165 $300.00

Wright Investors Service Comprehensive Report for Sun Pharmaceuticals Industries Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

06 Jul 2016 Wright Reports 60 $75.00

Wright Industry Averages: Pharmaceuticals & Biotechnology (India)

Wright Investors' Service Industry Averages - Pharmaceuticals & Biotechnology (India). Wright Industry Averages provide calcu...

21 Jun 2016 Wright Reports 68 $169.00

Company Snapshot - Sun Pharmaceuticals Industries

A director at Sun Pharmaceuticals Industries bought 7,200 shares at 0.000INR and the significance rating of the trade was 52/...

10 Jun 2016 Directors Deals Ltd. 1 $12.00

Sun Pharmaceutical Industries Limited (SUNPHARMA) - Financial and Strategic SWOT Analysis Review

Sun Pharmaceutical Industries Limited (SUNPHARMA) - Financial and Strategic SWOT Analysis Review Summary Sun Pharmaceutical I...

09 Jun 2016 GlobalData 160 $300.00

MOSL: SUN PHARMA 4QFY16 (Buy)-A strong quarter-Management provides modest FY17 top line guidance

SUN PHARMA 4QFY16: A strong quarter; Management provides modest FY17 top line guidance (SUNP IN, Mkt Cap USD27.3b, CMP INR76...

01 Jun 2016 Motilal Oswal Securities Ltd. 10 $104.00

Spark Capital: 4QFY16 outlook review of Sun Pharmaceutical Industries (Rating: ADD, TP: Rs. 792)

4QFY16 outlook review of Sun Pharmaceutical Industries (Rating: ADD, TP: Rs. 792) How does our one year outlook change? ...

01 Jun 2016 Spark Capital Advisors(India) Private Limited 6 $46.00

Sun Pharmaceuticals (SUNP) - Qtr. Update - Dated - May 31, 2016

Sun Pharma (Bloomberg: SUNP IN, HOLD, TP – Rs 790, 4% upside from CMP of Rs 763) Sun Pharma’s (Sun) Q4 PAT was 5% below ou...

01 Jun 2016 Axis Capital Limited 9 $92.00